Our Company
The Company's business model capitalizes on inventions and technology from which profits are created through licensing. MSI is dedicated to earning profit for its 8,600 shareholders by identifying, supporting, patenting and marketing technical innovation by harvesting top technology talent to bring game-changing product to the market.
We emphasize novel technology in the Nanomedicine space with the potential to be disruptive and the ability to establish sustainable businesses.
We are "patient capital" with experienced business building partners who bring the perspective of merchant bankers, not venture capitalists. Our approach to assist scientists to commercialize their work is by providing a forum within which the commercialization process is fostered through partnerships with existing companies (Fortune/1000 or larger). The entrepreneurial scientists and engineers who join us create personal success and wealth on an accelerated basis by virtue of ownership of publicly traded Manhattan Scientifics shares (OTC BB: MHTX).
more...Our News
February 23, 2012
National Foundation For Cancer Research Funds Novel Approach To Early Detection Of Ovarian Cancer
ALBUQUERQUE, N.M.--The National Foundation for Cancer Research has awarded a grant to Dr. Robert C. Bast, Jr. of The University of Texas MD Anderson Cancer Center to work with Senior Scientific LLC, a company owned by Manhattan Scientifics (OTCBB: MHTX), to apply Senior Scientifics’ technology to the early detection of ovarian cancer.
more...December 19, 2011
Fortune: Manhattan Scientifics Is A Leader In The Race For A Better Mammogram
NEW YORK--"The race is on for a better mammogram" states the December 19th headline in Fortune Magazine's (online) story by Sierra Jiminez. The story then begins—and ends—with the breakthrough work of Edward R. Flynn, PhD, of Manhattan Scientifics Inc.
more...December 15, 2011
Manhattan Scientifics CEO Issues Letter To Shareholders
Thank you for your investment in Manhattan Scientifics. I want to personally and corporately thank all our shareholders for their encouragement. I sincerely believe that 2012 is going to be a break-out year for Manhattan Scientifics.
more...October 31, 2011
“Breast Cancer Research” Publishes Key Study; Cancer-Sensing Technology Is Radiation-Free
ALBUQUERQUE, N.M.--Manhattan Scientifics (OTCBB: MHTX) announced today that “Breast Cancer Research,” an international, peer-reviewed online journal, has published results of a study using Senior Scientific’s nanomagnetic technology.
more...October 13, 2011
Watching Cancer Cells Disappear During Therapy
ALBUQUERQUE, N.M.--Manhattan Scientifics (OTCBB: MHTX) announced today that the National Cancer Institute (NCI) has funded a grant for its Senior Scientific, LLC unit, for the use of its proprietary, highly precise magnetic cancer cell measurement in leukemia research for determining the progress of cancer treatment.
more...October 1, 2011
Profiles In Versatility
A cabal of cacophonic college kids inspired Shahriar Afshar to become an entrepreneur. It was 2004, and the physicist was serving as a visiting professor at a college, temporarily residing in the dorms. "It was summer, and the kids loved playing video games and listen[ing] to loud music, which shook the whole building.
more...October 1, 2011
Breast Cancer: How Far Have We Come?
An easy at-home test? Drugs that slash your risk? These aren’t science fiction -- they’re real advances that are revolutionizing the way we find, treat and defeat this disease. Every October, we don pink ribbons, buy pink-hued products and support charity runs with pink logos. Has it made a difference? You bet.
more...Technology
Advanced Materials
Manhattan Scientifics has acquired the exclusive rights to the key patents and IP and will soon be positioned to enter into manufacturing and licensing agreements.
Nanomedicine
Manhattan Scientifics and Senior Scientific, LLC have announced that they have begun cooperative work to commercialize Senior Scientific's nano medicine cancer detection technology.
Dr. Ed Flynn's Technology Featured in Center for Integrated Nanotechnologies (CINT) Annual Report
Dr. Edward Flynn, founder and president of Senior Scientific, LLC, has developed a nanotechnology-based, magnetic imaging method for early diagnosis and treatment of cancer that could provide a significant increase in detection sensitivity.
more...Flynn uses physics and his brain to find new ways to detect, treat cancer
Dr. Edward Flynn could save lives with a new, ground-breaking technology intended to detect cancer much earlier than current techniques can.
